Re: Lysogene doings?
I see it was discussed yesterday on twitter:
These guys are thinking Sarepta would pay $200 million for the company. They must not know Sarepta! We've got too many possible programs in addition to the 40 or so we already have taken on to waste $200 million on one!!!!
If anything we do a deal like LRK's Myonexus and throw in some Sarepta shares and agree to take their second program to the clinic asap. We're not going to hand over a simple $200 million for the fun of it! That's a Pfizer type move. Stupid.